Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDe La Rue Regulatory News (DLAR)

  • This share is currently suspended. It was suspended at a price of 130.00
  • There is currently no data for DLAR

Rule 2.9 Announcement

1 Jul 2025 13:25

RNS Number : 2528P
De La Rue PLC
01 July 2025
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.

 

FOR IMMEDIATE RELEASE

 

1 July 2025

 

De La Rue plc ("De La Rue" or "Company")

 

Rule 2.9 Announcement

 

 

 

De La Rue announces that on 1 July 2025, it issued 4,864,009 ordinary shares of 44.8686 pence each in the capital of the Company ("Ordinary Shares") in satisfaction of the exercise of options under De La Rue Sharesave Scheme, De La Rue Sharesave Plan 2022, De La Rue Deferred Bonus Plan 2020, De La Rue Performance Share Plan, De La Rue Performance Share Plan 2020 and De La Rue Investor Returns Plan 2023. In accordance with Rule 2.9 of the City Code on Takeovers and Mergers (the "Code"), and further to the announcement made on 4 February 2025, as at the date of this announcement, De La Rue therefore has 201,296,031 Ordinary Shares in issue, each with voting rights, under the ISIN code GB00B3DGH821.

 

Jon Messent

Company Secretary

01256 605212

 

De La Rue plc's LEI code is 213800DH741LZWIJXP78

 

 

Disclosure requirements of the Code

Under Rule 8.3(a) of the Code, any person who is interested in 1% or more of any class of relevant securities of an offeree company or of any securities exchange offeror (being any offeror other than an offeror in respect of which it has been announced that its offer is, or is likely to be, solely in cash) must make an Opening Position Disclosure following the commencement of the offer period and, if later, following the announcement in which any securities exchange offeror is first identified. An Opening Position Disclosure must contain details of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror(s). An Opening Position Disclosure by a person to whom Rule 8.3(a) applies must be made by no later than 3.30 pm (London time) on the 10th business day following the commencement of the offer period and, if appropriate, by no later than 3.30 pm (London time) on the 10th business day following the announcement in which any securities exchange offeror is first identified. Relevant persons who deal in the relevant securities of the offeree company or of a securities exchange offeror prior to the deadline for making an Opening Position Disclosure must instead make a Dealing Disclosure.

Under Rule 8.3(b) of the Code, any person who is, or becomes, interested in 1% or more of any class of relevant securities of the offeree company or of any securities exchange offeror must make a Dealing Disclosure if the person deals in any relevant securities of the offeree company or of any securities exchange offeror. A Dealing Disclosure must contain details of the dealing concerned and of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror(s), save to the extent that these details have previously been disclosed under Rule 8. A Dealing Disclosure by a person to whom Rule 8.3(b) applies must be made by no later than 3.30 pm (London time) on the business day following the date of the relevant dealing.

If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire or control an interest in relevant securities of an offeree company or a securities exchange offeror, they will be deemed to be a single person for the purpose of Rule 8.3.

Opening Position Disclosures must also be made by the offeree company and by any offeror and Dealing Disclosures must also be made by the offeree company, by any offeror and by any persons acting in concert with any of them (see Rules 8.1, 8.2 and 8.4).

Details of the offeree and offeror companies in respect of whose relevant securities Opening Position Disclosures and Dealing Disclosures must be made can be found in the Disclosure Table on the Panel's website at www.thetakeoverpanel.org.uk, including details of the number of relevant securities in issue, when the offer period commenced and when any offeror was first identified. You should contact the Panel's Market Surveillance Unit on +44 (0)20 7638 0129 if you are in any doubt as to whether you are required to make an Opening Position Disclosure or a Dealing Disclosure.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RTTFLFFFDFILIIE
Date   Source Headline
23rd Nov 20227:00 amRNS2022/23 HALF YEAR RESULTS
22nd Nov 202210:39 amRNSHolding(s) in Company
10th Nov 20227:00 amRNSResponse to Crystal Amber's open letter
3rd Nov 20222:33 pmRNSNotice of GM
27th Oct 20221:00 pmRNSDE LA RUE PLC ANNOUNCES GENERAL MEETING
30th Sep 20224:41 pmRNSSecond Price Monitoring Extn
30th Sep 20224:35 pmRNSPrice Monitoring Extension
23rd Sep 20227:00 amRNSExtension of contract
13th Sep 202210:58 amRNSDirectorate Change
2nd Sep 20227:00 amRNSExecutive Changes in Authentication Division
1st Sep 202212:10 pmRNSDirector/PDMR Shareholding
10th Aug 20221:55 pmRNSDirector/PDMR Shareholding
1st Aug 202210:01 amRNSTotal Voting Rights
27th Jul 202211:53 amRNSResult of AGM
26th Jul 20225:11 pmRNSTERMINATION OF RELATIONSHIP AGREEMENT WITH PORTALS
11th Jul 20227:00 amRNSDirector/PDMR Shareholding
6th Jul 20221:47 pmRNSDirector/PDMR Shareholding
1st Jul 202210:46 amRNSBlock listing Interim Review
1st Jul 202210:40 amRNSTotal Voting Rights
24th Jun 202210:21 amRNSAnnual Financial Report
9th Jun 20221:38 pmRNSHolding(s) in Company
31st May 20229:25 amRNSHolding(s) in Company
25th May 20227:00 amRNSFY22 Full Year Results
23rd May 20221:03 pmRNSAdditional Listing
7th Apr 20227:00 amRNSTrading Update
1st Apr 202210:17 amRNSTotal Voting Rights
18th Mar 20227:00 amRNSUpdate on Responsible Business Activities
11th Mar 202210:45 amRNSHolding(s) in Company
3rd Mar 20227:00 amRNSPension Scheme funding update
1st Mar 202210:44 amRNSTotal Voting Rights
3rd Feb 20227:00 amRNSAuthentication Contract Win
1st Feb 20229:44 amRNSTotal Voting Rights
26th Jan 20222:46 pmRNSHolding(s) in Company
24th Jan 20227:00 amRNSTrading and Turnaround Plan Update
12th Jan 20225:48 pmRNSChange in Director's Particulars
5th Jan 20224:37 pmRNSDirector/PDMR Shareholding
4th Jan 202212:06 pmRNSBlock listing Interim Review
4th Jan 202212:02 pmRNSTotal Voting Rights
1st Dec 202111:59 amRNSTotal Voting Rights
24th Nov 20217:00 amRNS2021/22 HALF YEAR RESULTS
1st Nov 202111:55 amRNSTotal Voting Rights
15th Oct 202110:08 amRNSHolding(s) in Company
12th Oct 20217:00 amRNSTrading Statement
1st Oct 20212:24 pmRNSTotal Voting Rights
15th Sep 20217:00 amRNSAnnouncement Of Significant Expansion In Malta
1st Sep 202111:00 amRNSTotal Voting Rights
4th Aug 202111:30 amRNSHolding(s) in Company
2nd Aug 20219:58 amRNSTotal Voting Rights
29th Jul 20211:36 pmRNSResult of AGM
29th Jul 20217:00 amRNSAGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.